4.7 Article

cyy260 suppresses the proliferation, migration and tumor growth of osteosarcoma by targeting PDGFR-β signaling pathway

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

PDGFRI3 modulates aerobic glycolysis in osteosarcoma HOS cells via the PI3K/AKT/mTOR/c-Myc pathway

Hu-ying Tang et al.

Summary: This study demonstrated that PDGFRI3 has a positive regulatory role in glucose metabolism of osteosarcoma cells, promoting aerobic glycolysis through the activation of the PI3K/AKT/mTOR/c-Myc pathway. This newly discovered role provides a novel metabolic therapeutic target for osteosarcoma.

BIOCHEMISTRY AND CELL BIOLOGY (2022)

Article Pharmacology & Pharmacy

Narciclasine suppresses esophageal cancer cell proliferation and migration by inhibiting the FAK signaling pathway

Yinda Qiu et al.

Summary: Narciclasine inhibits proliferation and migration of esophageal cancer cells through FAK/JNK and p38 pathways, accompanied by DNA damage, cell cycle arrest, and apoptosis.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review

Xiang Zou et al.

Summary: The PDGF/PDGFR signaling pathway plays a crucial role in cancer, and targeting this pathway has become an effective strategy for cancer therapy with some progress in related research.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Chemistry, Medicinal

Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma

Xiaojing Chen et al.

Summary: This study investigated the design, synthesis, and structure-activity relationships of novel pyrimidine-2,4-diamine derivatives that selectively inhibit PDGFR alpha/beta kinases. Compound 7m showed the most promising activity against PDGFR alpha and beta, with low IC50 values. It also exhibited significant cytotoxic effects against osteosarcoma cancer cell lines, as well as robust antitumor effects and low toxicity in a xenograft model. The compound demonstrated favorable pharmacokinetic properties and showed potential as a drug candidate for PDGFR-driven osteosarcoma.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Pharmacology & Pharmacy

Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma

Zhi Xiong Chong et al.

Summary: Osteosarcoma, a prevalent primary bone tumor, has high metastatic potential and poor prognosis. MiRNAs play crucial roles in regulating the EMT process in osteosarcoma, which may offer insights for prognostic and therapeutic strategies.

PHARMACOLOGICAL RESEARCH (2021)

Article Plant Sciences

Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1-and NF-κB-modulated urokinase plasminogen activator inhibition

Chia-Hsuan Chou et al.

Summary: DHM inhibits metastasis in osteosarcoma cells by reducing urokinase plasminogen activator (uPA) expression as well as suppressing SP-1 and NF-kappa B. Additionally, DHM achieves its anti-metastatic effects through the ERK pathway.

PHYTOMEDICINE (2021)

Article Integrative & Complementary Medicine

Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage

Ding-fang Zhang et al.

Summary: The study found that PL exhibited stronger anticancer activity against CRPC compared to taxol, cisplatin (DDP), doxorubicin (Dox), or 5-Fluorouracil (5-FU), with fewer side effects in normal cells. Importantly, PL treatment significantly decreased cell adhesion to the extracellular matrix and inhibited the migration of CRPC cells through affecting the expression and distribution of focal adhesion kinase (FAK).

BMC COMPLEMENTARY MEDICINE AND THERAPIES (2021)

Article Biotechnology & Applied Microbiology

Inhibition of Jurkat T Cell Proliferation by Active Components of Rumex japonicus Roots Via Induced Mitochondrial Damage and Apoptosis Promotion

Yinda Qiu et al.

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2020)

Review Biochemistry & Molecular Biology

Carotenoids in Cancer Metastasis-Status Quo and Outlook

Lenka Koklesova et al.

BIOMOLECULES (2020)

Letter Oncology

Pazopanib in relapsed osteosarcoma patients: report on 15 cases

Alessandra Longhi et al.

ACTA ONCOLOGICA (2019)

Article Biochemistry & Molecular Biology

Chlorogenic acid inhibits osteosarcoma carcinogenesis via suppressing the STAT3/Snail pathway

Fang Zhang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Review Oncology

PDGF/PDGFR effects in osteosarcoma and the add-on strategy

Jie Xu et al.

CLINICAL SARCOMA RESEARCH (2018)

Article Biotechnology & Applied Microbiology

CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration

Yuling Xi et al.

ONCOTARGETS AND THERAPY (2014)

Article Medicine, Research & Experimental

Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress

Vishnu Chintalgattu et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Review Cell Biology

Role of platelet-derived growth factors in physiology and medicine

Johanna Andrae et al.

GENES & DEVELOPMENT (2008)